INHIBITORY AND REGULATORY BINDING-SITES ON THE RAT-BRAIN SEROTONIN TRANSPORTER - MOLECULAR-WEIGHT OF THE [H-3] PAROXETINE AND [H-3] CITALOPRAM BINDING-PROTEINS

被引:42
作者
PLENGE, P
MELLERUP, ET
NIELSEN, M
机构
[1] RIGSHOSP,INST PSYCHOCHEM,DK-2100 COPENHAGEN,DENMARK
[2] SCI HANS HOSP,DEPT E,PSYCHOPHARMACOL RES LAB,DK-4400 ROSKILDE,DENMARK
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1990年 / 189卷 / 2-3期
关键词
H-3]PAROXETINE; H-3]CITALOPRAM; 5-HYDROXYTRYPTAMINE (5-HT) TRANSPORT COMPLEX; RECEPTOR MODULATION; BRAIN (RAT);
D O I
10.1016/0922-4106(90)90016-Q
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Citalopram binds with high affinity to a specific binding site located on the serotonin (5-HT) transporter in 5-HT neurons. The binding affinity of [H-3]citalopram was found to increase with increasing concentration of citalopram. This may be a homotropic positive allosteric effect, thus indicating the presence of an allosteric binding site for citalopram. The molecular weight of the proteins containing the high-affinity binding sites for citalopram and paroxetine, as well as the allosteric binding site for citalopram were determined by the irradiation method. The molecular weights of the three binding site proteins were found to be the same, suggesting that all three binding sites are located on the same protein molecule in the 5-HT transporter. The results support a hypothesis that the binding area for [H-3]citalopram is located deeper in the transport channel than the [H-3]paroxetine binding area. Thus the two high-affinity binding sites probably cover different, but overlapping, parts of the protein molecule. The allosteric binding site may be located elsewhere on the protein where it induces conformational changes of the 5-HT transporter with the result that high-affinity bound ligands get trapped in the transport channel, thereby explaining the increase in affinity.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 21 条
  • [1] QUANTITATIVE AUTORADIOGRAPHY OF [H-3]INDALPINE BINDING-SITES IN THE RAT-BRAIN .1. PHARMACOLOGICAL CHARACTERIZATION
    BENAVIDES, J
    SAVAKI, HE
    MALGOURIS, C
    LAPLACE, C
    MARGELIDON, C
    DANIEL, M
    COURTEIX, J
    UZAN, A
    GUEREMY, C
    LEFUR, G
    [J]. JOURNAL OF NEUROCHEMISTRY, 1985, 45 (02) : 514 - 520
  • [2] Bennett J., 1985, NEUROTRANSMITTER REC, V2nd, P61
  • [3] DAMATO RJ, 1987, J PHARMACOL EXP THER, V242, P364
  • [4] INSITU MOLECULAR SIZES OF THE VARIOUS TYPES OF 5-HT BINDING-SITES IN THE RAT-BRAIN
    GOZLAN, H
    EMERIT, MB
    HALL, MD
    NIELSEN, M
    HAMON, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (11) : 1891 - 1897
  • [6] KEMPNER ES, 1979, ANAL BIOCHEM, V92, P2, DOI 10.1016/0003-2697(79)90617-1
  • [7] MEMBRANE ENZYME SYSTEMS MOLECULAR SIZE DETERMINATIONS BY RADIATION INACTIVATION
    KEPNER, GR
    MACEY, RI
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1968, 163 (02) : 188 - &
  • [8] DISSOCIATION KINETICS OF [H-3] PAROXETINE BINDING TO RAT-BRAIN CONSISTENT WITH A SINGLE-SITE MODEL OF THE ANTIDEPRESSANT BINDING 5-HYDROXYTRYPTAMINE UPTAKE SITE
    MARCUSSON, J
    ERIKSSON, K
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 51 (05) : 1477 - 1481
  • [9] SPECIFIC BINDING OF [H-3]IMIPRAMINE TO PROTEASE-SENSITIVE AND PROTEASE-RESISTANT SITES
    MARCUSSON, J
    FOWLER, CJ
    HALL, H
    ROSS, SB
    WINBLAD, B
    [J]. JOURNAL OF NEUROCHEMISTRY, 1985, 44 (03) : 705 - 711
  • [10] HIGH-AFFINITY BINDING OF [H-3]LABELED PAROXETINE AND [H-3]IMIPRAMINE TO HUMAN-PLATELET MEMBRANES
    MELLERUP, ET
    PLENGE, P
    ENGELSTOFT, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 96 (3-4) : 303 - 309